Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Written by leading American practitioners, the Oxford American Handbooks of Medicine each offer a pocket-sized overview of an entire specialty, featuring instant access to guidance on the conditions that are most likely to be encountered. Precise and prescriptive, the handbooks offer up-to-date advice on examination, investigations, common procedures, and in-patient care. These books will be invaluable resources for residents and students, as well as a useful reference for practitioners. The essential reference for medical students, residents, and clinical oncologists seeking a current, portab

Cancer --- Oncology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

No area of cancer supportive care better illustrates the advances in our understanding of cellular and molecular biology, genetic engineering and the development of more effective yet often more toxic cancer treatments than that of hematopoietic growth factors. Myelosuppressive agents, with their potential hematopoietic toxicities, remain the mainstay of systemic treatment for both metastatic and early stage cancer. Hematopoietic Growth Factors in Oncology reviews and integrates the major advances in our understanding of the underlying molecular biology and pharmacology of these agents along with the results of well designed and executed randomized controlled trials of the erythroid stimulating agents, the myeloid growth factors and the new thrombopoietic agents, each addressing a major threat associated with bone marrow suppression accompanying cancer treatment. "Hematopoietic growth factors have revolutionized the treatment of patients with a spectrum of cancers and benign bone marrow disorders. This text addresses the mechanism of action and clinical impact of these cytokines. Leading investigators in the field provide and update of current state of knowledge and future challenges." – Steven T. Rosen, M.D. Series Editor.

Cancer -- Chemotherapy. --- Electronic books. -- local. --- Hematopoietic growth factors -- Therapeutic use. --- Hematopoietic growth factors --- Oncology --- Hematopoietic Cell Growth Factors --- Diseases --- Glycoproteins --- Biological Science Disciplines --- Therapeutics --- Proteins --- Natural Science Disciplines --- Cytokines --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Colony-Stimulating Factors --- Drug Therapy --- Neoplasms --- Pharmacology --- Amino Acids, Peptides, and Proteins --- Intercellular Signaling Peptides and Proteins --- Disciplines and Occupations --- Peptides --- Chemicals and Drugs --- Biological Factors --- Medicine --- Health & Biological Sciences --- Mechanism of action --- Cancer --- Therapeutic use. --- Chemotherapy. --- Hematopoietic cell growth factors --- Hematopoietins --- HGF (Growth factors) --- Medicine. --- Oncology. --- Medicine & Public Health. --- Antineoplastic agents --- Growth factors --- Treatment --- Oncology  . --- Tumors

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

No area of cancer supportive care better illustrates the advances in our understanding of cellular and molecular biology, genetic engineering and the development of more effective yet often more toxic cancer treatments than that of hematopoietic growth factors. Myelosuppressive agents, with their potential hematopoietic toxicities, remain the mainstay of systemic treatment for both metastatic and early stage cancer. Hematopoietic Growth Factors in Oncology reviews and integrates the major advances in our understanding of the underlying molecular biology and pharmacology of these agents along with the results of well designed and executed randomized controlled trials of the erythroid stimulating agents, the myeloid growth factors and the new thrombopoietic agents, each addressing a major threat associated with bone marrow suppression accompanying cancer treatment. "Hematopoietic growth factors have revolutionized the treatment of patients with a spectrum of cancers and benign bone marrow disorders. This text addresses the mechanism of action and clinical impact of these cytokines. Leading investigators in the field provide and update of current state of knowledge and future challenges." - Steven T. Rosen, M.D. Series Editor

Oncology. Neoplasms --- oncologie